WHO Call for Consultation: Preferred product characteristics for medicines for malaria chemoprevention
The WHO Global Malaria Programme (GMP) is seeking public comment on preferred product characteristics (PPCs) for medicines for malaria chemoprevention. PPCs are becoming a key tool for WHO to incentivize and guide the development of urgently needed health products. Consultation deadline August 22, 2022.